ANEB

Stock

Anebulo Pharmaceuticals, Inc. Common Stock

$0.47— (—)

52-Week Range

$0.36

$3.33

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

—

Volume

—

Avg Volume

186.4K

Performance

-24.84%

-83.41%

-85.54%

YTD

-68.14%

-76.92%

-85.60%

-94.93%

Price Chart

ETF Exposure

ANEB is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	12	$17	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	437	$621	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$3	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	248,953	$261K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,309	$2K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	112	$160	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	116,246	$122K	$84.10B	0.05%

About ANEB ETF Exposure

Anebulo Pharmaceuticals, Inc. Common Stock (ANEB) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.47. Investors can gain exposure to ANEB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ANEB, sorted by portfolio weight.